| Name | Title | Contact Details |
|---|
Orbus Therapeutics is dedicated to developing products that treat rare diseases for which there are few, if any, effective therapies. The company’s product candidate in development is eflornithine in an oral solution. Eflornithine is a novel cytostatic agent, which Orbus Therapeutics is developing for the treatment of patients with anaplastic glioma (AG), or Grade 3 glioma, a rare form of central nervous system cancer. Eflornithine irreversibly inhibits ornithine decarboxylase (ODC), a key enzyme in mammalian polyamine biosynthesis that is up-regulated in various types of cancer. Orbus Therapeutics intends to develop and commercialize eflornithine in North America.
We are dedicated to delivering excellent customer service as we build and maintain an environment that balances the needs of our valued employees and the organization. Our development of policies, programs, and services will promote accountability, involvement, diversity, and high performance, while ensuring compliance.
Moran Vista Assisted Living is a Spokane, WA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
MetaWorks is a Medford, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Luna NanoWorks is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Danville, VA. To find more information about Luna NanoWorks, please visit www.lunananoworks.com